Wellness Clinic Prana IV Therapy Discusses Nutritional Gaps Linked to GLP-1 Weight Loss Drugs
SCOTTSDALE, Ariz., May 21, 2026 /PRNewswire/ -- The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has sparked discussion around the potential nutritional impact of these drugs as millions of patients use them for weight loss and diabetes management. Prana IV Therapy,...
View original →